These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6120167)

  • 21. Monoclonal antibody-toxin conjugates reactive against human T lymphocytes. A comparison of antibody linked to intact ricin toxin with antibody linked to ricin A chain.
    Vallera DA; Quinones RR; Azemove SM; Soderling CC
    Transplantation; 1984 Apr; 37(4):387-92. PubMed ID: 6231750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of ricin on biosynthesis of myeloma protein (IgA) and general cellular proteins in MOPC-315 cells.
    Ko TS; Kaji A
    Biochim Biophys Acta; 1975 Dec; 414(2):155-60. PubMed ID: 1191708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetics of protein synthesis inactivation in human T-lymphocytes by selective monoclonal antibody-ricin conjugates.
    Leonard JE; Wang QC; Kaplan NO; Royston I
    Cancer Res; 1985 Nov; 45(11 Pt 1):5263-9. PubMed ID: 3876881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of the helper function of murine T cells with Fab'-anti-L3T4 ricin A chain immunotoxin.
    Street NE; Fulton RJ; Sanders VM; Vitetta ES
    J Immunol; 1987 Sep; 139(5):1734-8. PubMed ID: 2957434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resistance of Tetrahymena to ricin, a toxic enzyme from Ricinus communis.
    Wilde CG; Boguslawski S; Houston LL
    Biochem Biophys Res Commun; 1979 Dec; 91(3):1082-8. PubMed ID: 118750
    [No Abstract]   [Full Text] [Related]  

  • 26. On the role of the covalent carbohydrate in the action of ricin.
    Simeral LS; Kapmeyer W; MacConnell WP; Kaplan NO
    J Biol Chem; 1980 Dec; 255(23):11098-101. PubMed ID: 6254960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel synthesis and in vitro characterization of disulfide-linked ricin-monoclonal antibody conjugates devoid of galactose binding activity.
    Pietersz GA; Kanellos J; McKenzie IF
    Cancer Res; 1988 Aug; 48(16):4469-76. PubMed ID: 3260814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of a novel high-affinity monoclonal immunoglobulin G antibody against the ricin B subunit.
    McGuinness CR; Mantis NJ
    Infect Immun; 2006 Jun; 74(6):3463-70. PubMed ID: 16714577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunotoxins: hybrid molecules combining high specificity and potent cytotoxicity.
    Jansen FK; Blythman HE; Carrière D; Casellas P; Gros O; Gros P; Laurent JC; Paolucci F; Pau B; Poncelet P; Richer G; Vidal H; Voisin GA
    Immunol Rev; 1982; 62():185-216. PubMed ID: 7042538
    [No Abstract]   [Full Text] [Related]  

  • 30. Actin polymerization accompanies Thy-1-capping on mouse thymocytes.
    Laub F; Kaplan M; Gitler C
    FEBS Lett; 1981 Feb; 124(1):35-8. PubMed ID: 6111471
    [No Abstract]   [Full Text] [Related]  

  • 31. A flexible peptide spacer increases the efficacy of holoricin anti-T cell immunotoxins.
    Marsh JW; Neville DM
    J Immunol; 1988 May; 140(10):3674-8. PubMed ID: 2896212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Homology between ricin and Ricinus communis agglutinin: amino terminal sequence analysis and protein synthesis inhibition studies.
    Cawley DB; Hedblom ML; Houston LL
    Arch Biochem Biophys; 1978 Oct; 190(2):744-55. PubMed ID: 718174
    [No Abstract]   [Full Text] [Related]  

  • 33. Antigenic modulation by anti-CD5 immunotoxins.
    Manske JM; Buchsbaum DJ; Azemove SM; Hanna DE; Vallera DA
    J Immunol; 1986 Jun; 136(12):4721-8. PubMed ID: 3086441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A conjugate of alpha-amanitin and monoclonal immunoglobulin G to Thy 1.2 antigen is selectively toxic to T lymphoma cells.
    Davis MT; Preston JF
    Science; 1981 Sep; 213(4514):1385-8. PubMed ID: 6115471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoclonal antibody targeting of anti-cancer agents.
    Baldwin RW; Byers VS
    Springer Semin Immunopathol; 1986; 9(1):39-50. PubMed ID: 2425442
    [No Abstract]   [Full Text] [Related]  

  • 36. [Selective cytotoxicity of an antibody-ricin A chain conjugate for human tumor cells].
    Tonevitskiĭ AG
    Mol Biol (Mosk); 1985; 19(4):1034-41. PubMed ID: 4047033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monoclonal antibody-ricin or ricin A chain hybrids: kinetic analysis of cell killing for tumor therapy.
    Neville DM; Youle RJ
    Immunol Rev; 1982; 62():75-91. PubMed ID: 7042541
    [No Abstract]   [Full Text] [Related]  

  • 38. Toxicity of a monoclonal F(ab')2:ricin A conjugate for retinoblastoma in vitro.
    Merriam JC; Lyon HS; Char DH
    Cancer Res; 1984 Aug; 44(8):3178-83. PubMed ID: 6744258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transport of ricin A chain after prior treatment of mouse leukemia cells with ricin B chain.
    Houston LL
    J Biol Chem; 1982 Feb; 257(3):1532-9. PubMed ID: 7056731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inactivation of Ricin using 4-azidophenyl-beta-D-galactopyranoside and 4-diazophenyl-beta-D-galactopyranoside.
    Houston LL
    J Biol Chem; 1983 Jun; 258(11):7208-12. PubMed ID: 6853515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.